Books > Business & Economics > Economics > International economics > International trade
|
Buy Now
Pharmaceutical Patent Protection and World Trade Law - The Unresolved Problem of Access to Medicines (Hardcover)
Loot Price: R4,148
Discovery Miles 41 480
|
|
Pharmaceutical Patent Protection and World Trade Law - The Unresolved Problem of Access to Medicines (Hardcover)
Series: Routledge Research in Intellectual Property
Expected to ship within 12 - 17 working days
|
Patents, including pharmaceutical patents, enjoy extended
protection for twenty years under the TRIPs Agreement. The
Agreement has resulted in creating a two-tier system of the World
Trade Organisation Member States, and its implementation has seen
the price of pharmaceutical products skyrocket, putting essential
medicines beyond the reach of the common man. The hardest hit
populations come from the developing and least developed countries,
which have either a weak healthcare system or no healthcare at all,
where access to essential and affordable medicines is extremely
difficult to achieve. Pharmaceutical Patent Protection and World
Trade Law studies the problems faced by these countries in
obtaining access to affordable medicines for their citizens in
light of the TRIPS Agreement. It explores the opportunities that
are still open for some developing countries to utilise the
flexibilities available under the TRIPS Agreement in order to
mitigate the damage caused by it. The book also examines the
interrelationship between the world governing bodies, and the right
to health contained in some of the developing country's national
constitutions.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.